NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed

NeoGenomics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $23.4. The average 1-year stock price forecast is 51.85% higher than the current stock price, while the lowest is $19 (+23.30%) and the highest is $35 (+127.13%).

Price Target: $23.4 (+51.85%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$19$23.4$22$35
Change+23.30%+51.85%+42.76%+127.13%

Analyst Ratings

The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy666666
Buy222222
Hold444443
Sell000000
Strong Sell000000
Total121212121211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 29, 2026
TD Cowen
TD Cowen
Buy
Maintains
$19 → $23
BuyMaintains$19 → $23+49.25%Oct 29, 2026
Jefferies
Jefferies
Buy
Maintains
$17 → $21
BuyMaintains$17 → $21+36.28%Oct 29, 2026
Needham
Needham
Buy
Reiterates
$22
BuyReiterates$22+42.76%Oct 29, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
$35
BuyReiterates$35+127.13%Oct 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
808.21M
from 727.33M
Increased by 11.12%
Revenue Next Year
886.46M
from 808.21M
Increased by 9.68%
EPS This Year
0.20
from 0.12
Increased by 69.17%
EPS Next Year
0.34
from 0.20
Increased by 67.49%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
484.33M509.73M591.64M660.57M727.33M808.21M
Revenue Growth
8.97%5.24%16.07%11.65%10.11%11.12%
Gross Profit
187.06M187.90M244.60M290.10M313.89M365.85M
Gross Margin
38.62%36.86%41.34%43.92%43.16%45.27%
Operating Income
-118.75M-153.11M-96.65M-71.10M-69.65M-48.26M
Net Income
-8.35M-144.25M-87.97M-78.73M-108.03M-31.50M
EPS
----0.120.20
EPS Growth
----9.09%69.17%
Forward PE
266.98266.98266.98103.9183.5875.91
Free Cash Flow
-----23.01M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High808.6M
Avg808.2M
Low807.7M

Revenue Growth

Revenue Growth202620272028
High
11.2%
Avg
11.1%
Low
11.0%

EPS Forecast

EPS202620272028
High0.22
Avg0.20
Low0.18

EPS Growth

EPS Growth202620272028
High
83.3%
Avg
69.2%
Low
50.0%